[18F]FES is FDA-approved since 2020, and is now distributed in Israel by S.R.Y Medical Services. [18F]FES is an analogue of estradiol that binds the estrogen receptor (ER) with high affinity and selectivity1. It is indicated for detecting ER-positive lesions, as an adjunct to biopsy, in patients with recurrent or metastatic breast cancer2. Current SNMMI/ EANM […]
S.R.Y. (Specialized Medical Services) is an Israeli company that manufactures and develops radiopharmaceuticals for diagnosis, treatment and medical research. The company operates the cyclotron unit at Hadassah Ein Kerem Hospital and produces medical isotopes in an advanced nuclear pharmacy.
All information on this site is general only and should not be considered in any way medical advice, treatment recommendation, a substitute for treatment, or a recommendation for a pharmaceutical preparation. Therefore, the content and information should not be relied upon for the purpose of receiving or providing medical treatment, and the information is not a substitute for the instructions in the consumer leaflet or for consultation with a qualified medical professional.
S.R.Y. (Specialized Medical Services) strives to provide as up-to-date and reliable information as possible on this site, but does not guarantee the completeness or completeness of the information on the site. Any use of the information on the site is the sole responsibility of the users.
